| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |